-
Startseite
-
a-t-Archiv
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Geschenkabo
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
 
 
  NEW ON THE MARKET
 

Agomelatine (VALDOXAN) for major depressive disorder

Low dose orlistat (ALLI) now OTC

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Clopidogrel and aspirin in patients with atrial fibrillation

Valsartan (DIOVAN): no protection against atrial fibrillation

Strict control of blood glucose in critical ill patients?

 
  a-t READER'S QUESTIONS AND COMMENTS
 

For how long adjuvant tamoxifen (e.g. NOLVADEX) in breast cancer

 
  IN BRIEF
 

Pharmaceutical quality of all tested gabapentin products okay

Calcium dobesilate without benefit in diabetic retinopathy

Merck & Co: dubious marketing strategies

 
  CURRENT ADR NETWORK REPORT
 

Are disposal boxes for syringes sufficient safe?

Erratum: non vertebral fractures due to ibandronate (e.g. BONVIVA)

 
  SIDE EFFECTS
 

Sertindole (SERDOLECT): Cardiotoxicity confirmed

Strontium ranelate (PROTELOS) causes alopecia

Gastrointestinal perforation due to erlotinib (TARCEVA)

 
© arznei-telegramm 5/2009